BackPOLITICS
Timeline: Makary resigns as FDA chief over flavored vape decision
Marty Makary stepped down as FDA commissioner amid internal tensions and a policy clash over authorizing fruit-flavored vaping products. The White House proceeded with the flavored-vape authorization despite his objections, culminating in his exit, a presidential acknowledgment, and a subsequent appointment of an acting commissioner.
Why It Matters
The resignation highlights regulatory tensions within the administration and ongoing debate over youth vaping risks and the agency’s policy direction.
Timeline
6 Events
Kyle Diamantas named acting FDA commissioner
May 12, 2026
Following Makary's exit, FDA official Kyle Diamantas was named acting commissioner as the agency prepared for a permanent replacement.
Trump acknowledges Makary's resignation
May 12, 2026
President Donald Trump acknowledged the resignation to reporters and said Makary was a great doctor but faced difficulties in his role.
Makary resigns as FDA chief
May 12, 2026
Marty Makary resigned as FDA commissioner on May 12, 2026, after weeks of internal pressure and conflict over the flavored vape decision.
Makary privately opposes the policy and communicates his stance
May 2026
Makary told close associates he could not support the flavored vape decision and believed it posed risks to young people, aligning with his publicized concerns and disagreements with the policy.
White House authorizes fruit-flavored vaping products
May 2026
The administration moved ahead with authorizing fruit-flavored vaping products, a decision Makary privately opposed.
Rising internal FDA tensions and anticipated removal
April 2026
Weeks of internal pressure and growing tension inside the FDA preceded Makary's departure, with officials reportedly anticipating a possible firing or forced exit before he stepped down.